Bleeding in Patients Undergoing CABG (Coronary Artery Bypass Graft) During Dual Antiplatelet Therapy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

144 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-11-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study is to evaluate surgery-related bleeding and mortality in patients needing acute coronary artery bypass grafting with or without valve replacement during dual antiplatelet therapy with aspirin and a P2Y12 receptor blocker (Clopidogrel, Prasugrel, Ticagrelor)

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery

NCT01606865

Postoperative Bleeding

COMPLETED

Platelet Inhibition and Bleeding in Patients Undergoing Emergent Cardiac Surgery

NCT01468597

Bleeding

COMPLETED

Thrombelastogram in Patients Receiving Antiplatelet Medication Undergoing Cardiac Surgery

NCT00778492

Bleeding

UNKNOWN

Platelet Reactivity in Patients on a Thienopyridine and Awaiting Coronary Artery Bypass Grafting

NCT01406483

Complication of Coronary Artery Bypass Graft Peri-operative Hemorrhage or Hematoma Post Operative Bleeding

COMPLETED NA

Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery

NCT00396760

Bleeding and Cardiac Surgery Allogeneic Blood Transfusion Aortic Valve Replacement +1 more

UNKNOWN PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

acute CABG

patients undergoing acute CABG with or without valve replacement during dual antiplatelet therapy

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

consecutive patients undergoing acute CABG with or without valve replacement within 7 days after last intake of dual antiplatelet therapy

Exclusion Criteria

concomitant oral anticoagulants dialysis surgery employing hypothermic cardiac arrest

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elisabeth Mahla, MD

Role: PRINCIPAL_INVESTIGATOR

Dept. of Anesthesiology and Intensive Care Medicine, MUG

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept. of Anesthesiology and Intensive Care Medicine

Graz, Styria, Austria

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS003684

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery

NCT00825981 COMPLETED

Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery

NCT00914589 COMPLETED PHASE2

Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T)

NCT04976530 COMPLETED NA

Tranexamic Acid in On-pump CABG With Premature Clopidogrel Cessation

NCT01596738 COMPLETED NA

Topical Application of Tranexamic Acid to Reduce Post-operative Bleeding in Coronary Artery Bypass Surgery

NCT01519245 COMPLETED PHASE3

Study of Local Administration of DepoTXA for Reduced Postsurgical Bleeding in Subjects Undergoing TKA

NCT02922582 TERMINATED PHASE2

A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery

NCT00588133 COMPLETED PHASE3

Reducing Post Operative Bleeding Following Cabg

NCT01600599 COMPLETED NA

Tranexamic Acid, Hemorrhage and Transfusions After Combined Aortic Valve Replacement and Coronary Artery Bypass Surgery.

NCT00375466 COMPLETED NA

Observational Study of Platelet Dysfunction Assessed by Thromboelastography in Cardiovascular Surgery (DISPLATEG)

NCT06961175 RECRUITING

Safety of Topical Tranexamic Acid in Total Joint Arthroplasty in High Risk Patients

NCT02644473 WITHDRAWN PHASE4

Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery

NCT02097602 COMPLETED

Efficacy and Safety of Topical Application of Tranexamic Acid for Saving Blood Losses in Patients Subjected to Prosthetic Knee Surgery

NCT03386656 COMPLETED PHASE3

Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery

NCT01358422 COMPLETED

Noninferiority Oral Tranexamic Acid vs Intravenous Administration in Total Hip Arthroplasty

NCT04691362 COMPLETED PHASE4

Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery

NCT00516126 COMPLETED

Mechanistic Study of Bleeding Risk in Coronary Patients With Cerebrovascular Disease

NCT02316119 COMPLETED

Perioperative Management of Factor Xa Inhibitors

NCT05801068 ACTIVE_NOT_RECRUITING NA

Bridge or Continue Coumadin for Device Surgery Randomized Controlled Trial

NCT00800137 TERMINATED PHASE4

Perioperative Ischemia Versus Perioperative Bleeding During Non-cardiac Surgery in Cardiac Patients

NCT01897220 COMPLETED

Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty

NCT02865174 UNKNOWN PHASE4

Prediction of Bleeding and Transfusion Outcomes and Assessment of Perioperative Platelet Reactivity in Cardiac Surgery

NCT02277379 COMPLETED

Safety and Efficacy of Fibrinogen Concentrate in Aortic Arch Surgery Involving Moderate Hypothermic Circulatory Arrest

NCT02542306 UNKNOWN PHASE2

Prevention of Bleeding in Total Joint Replacement: Combined Route Administration of Tranexamic Acid

NCT05874583 COMPLETED NA

Tranexamic Acid in Urologic Surgery

NCT00670345 COMPLETED PHASE4